What we know — and don't — about why the FDA banned Juul; Doudna reflects on CRISPR's first decade

Experts were surprised that the FDA blamed Juul's toxicology data when it banned the company from selling its e-cigarettes.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT readers, we want to hear from you. We're putting together a list of books and podcasts that deal with health, medicine, and the life sciences that would be great to check out this summer. Submit your pick here. STAT+: What we know — and what we may never know — about why the FDA banned Juul By Nicholas Florko Justin Sullivan/Getty Images STAT spoke with several tobacco regulatory experts about the FDA’s issues with Juul’s toxicology data. They were surprised by its reasoning. Read More Tracking an FDA advisory panel meeting on updating Covid vaccines By Helen Branswell and Matthew Herper Eugene Hoshiko/AP The Vaccines and Related Biological Products Advisory Committee is meeting to discuss key issues about the composition of Covid vaccines. Read More CRISPR debuted 10 years ago, in a paper hardly anyone noticed. Jennifer Doudna reflects on the DNA scissors' first decade By Megan Molteni Jeff Chiu/AP Nobelist Jennifer Doudna talks about the decade since she co-authored the landmark paper on using CRISPR as "programmable DNA scissors." Read More Sponsor content by YouTube Increasing access to authoritative health information through video People around the world need better access to high quality health information. That's why YouTube Health is working with the National Health Service to make it easier for people to find information from authoritative sources on YouTube. New features launched in the United Kingdom show labels on videos from authoritative sources, and videos from these sources may be shown in shelves for certain health-related search queries on YouTube. Learn more. STAT+: Cognito Therapeutics raises $50 million for Alzheimer's treatment tech By Mario Aguilar Adobe Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline.  Read More 'It's not going to work': Keeping race out of machine learning isn't enough to avoid bias By Katie Palmer Adobe Researchers at MIT and IBM Research have shown that algorithms based solely on clinical notes could predict self-identified race. Read More Placebo response reveals unconscious bias among white patients toward female, Black physicians By Katherine Gilyard Adobe A study using the placebo response shows how patients' unconscious reactions to their doctor's gender or race may steer health outcomes. Read More In Boston homes, potentially harmful compounds are leaking from stovetops By Edward Chen Adobe Researchers are concerned we don't have a firm enough handle on the potential health effects of natural gas in the home. Read More Opinion: The next epidemic may be here. The U.S. isn't ready for it By David C. Harvey NIAID Monkeypox isn't technically a sexually transmitted infection, but looks and acts like one and has the same barriers to detection and treatment. Read More Tuesday, June 28, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser